Hydroxychloroquine treatment for severe COVID‐19 pulmonary infection (HYDRA Trial)  Drug: hydroxychloroquine, drug: placebo oral tablet  COVID‐19 severe acute respiratory syndrome  500, all, 18–0  Treatment  Active comparator: treatment